Patient-Friendly Explanation
Lipocalin-2, also called NGAL, is a protein produced by fat cells that rises in the blood when there is inflammation and excess body fat. Higher levels are linked to obesity and problems with how the body handles blood sugar. It is being studied as a possible early warning sign of metabolic trouble.
Clinical Definition
Lipocalin-2 (neutrophil gelatinase-associated lipocalin, NGAL) is an adipokine secreted by adipose tissue and activated neutrophils, circulating at elevated concentrations in obesity, insulin resistance and type 2 diabetes. It binds siderophores and is implicated in inflammation, appetite regulation and glucose homeostasis, though its exact role remains debated. Serum lipocalin-2 correlates positively with BMI and markers of metabolic syndrome, making it a candidate biomarker of adipose dysfunction.
Why It Matters
Understanding markers like lipocalin-2 helps explain why excess fat tissue is not simply storage but an active organ that drives inflammation. NuLifeCare Singapore uses evidence like this to personalise weight management, aiming to reduce inflammation and improve metabolic health, not just lower the scale.